J Korean Med Sci.  2017 Nov;32(11):1792-1799. 10.3346/jkms.2017.32.11.1792.

Validation Study for the Korean Version of Fear of Cancer Recurrence Inventory

Affiliations
  • 1Department of Family Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
  • 2Department of Family Medicine, National Center for Mental Health, Seoul, Korea.
  • 3Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. yunmisong@skku.edu
  • 4Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 5Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada.

Abstract

Fear of cancer recurrence (FCR) is one of the most prevalent unmet psychosocial needs. This study aimed to confirm the cultural equivalence, reliability, and validity of the Korean version of Fear of Cancer Recurrence Inventory (K-FCRI). We conducted a forward-backward translation of the English version FCRI to Korean version through meticulous process including transcultural equivalence test. The psychometric property of the K-FCRI was then validated in 444 survivors from cancers at various sites. The Korean translation was accepted well by participants. There was a good cultural equivalence between the Korean version and the English version of FCRI. Confirmatory factor analysis supported the original seven-factor structure with slightly insufficient level of goodness-of-fit indices (comparative fit index = 0.900, non-normed fit index = 0.893, root mean square error of approximation = 0.060). The K-FCRI had high internal consistency (α = 0.85 for total scale and α = 0.77-0.87 for subscales) and test-retest reliability (r = 0.90 for total scale and r = 0.54-0.84 for subscales). The K-FCRI had significant correlations with the Korean version of Fear of Progression Questionnaire, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Version 3.0, Hospital Anxiety and Depression Scale, and Fatigue Severity Score, supporting the good construct validity and psychometric properties of K-FCRI. The K-FCRI was confirmed as a valid and reliable psychometric test for measuring FCR of Korean survivors from cancers at various sites.

Keyword

Fear; Neoplasms; Recurrence; Survivors; Validation Studies

MeSH Terms

Anxiety
Depression
Fatigue
Humans
Psychometrics
Quality of Life
Recurrence*
Reproducibility of Results
Survivors

Cited by  3 articles

What influences aromatase inhibitor continuation intention among breast cancer survivors?
Young Kyung Seo, Jeongok Park, Jin-Hee Park, Sue Kim
Korean J Women Health Nurs. 2021;27(1):49-57.    doi: 10.4069/kjwhn.2021.01.19.

Factors Influencing the Improvement in Lifestyle Among Patients with Colorectal Cancer
Song Ok Lim, Sangeun Jun
Korean J Adult Nurs. 2019;31(3):325-336.    doi: 10.7475/kjan.2019.31.3.325.

Psychometric Validation of the Korean Version of the Cancer Survivors’ Unmet Needs (CaSUN) Scale among Korean Non–Small Cell Lung Cancer Survivors
Danbee Kang, Genehee Lee, Sooyeon Kim, Heesu Nam, Sunga Kong, Sungkeun Shim, Jae Kyung Lee, Wonyoung Jung, Sumin Shin, Hong Kwan Kim, Jae Ill Zo, Young Mog Shim, Dong Wook Shin, Juhee Cho
Cancer Res Treat. 2023;55(1):61-72.    doi: 10.4143/crt.2021.1583.


Reference

1. Vickberg SM. The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003; 25:16–24.
2. Lebel S, Simard S, Harris C, Feldstain A, Beattie S, McCallum M, Lefebvre M, Savard J, Devins GM. Empirical validation of the English version of the Fear of Cancer Recurrence Inventory. Qual Life Res. 2016; 25:311–321.
3. Stewart DE, Duff S, Wong F, Melancon C, Cheung AM. The views of ovarian cancer survivors on its cause, prevention, and recurrence. Medscape Womens Health. 2001; 6:5.
4. van den Beuken-van Everdingen MH, Peters ML, de Rijke JM, Schouten HC, van Kleef M, Patijn J. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psychooncology. 2008; 17:1137–1145.
5. Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2013; 22:978–986.
6. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; 7:300–322.
7. Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012; 21:571–587.
8. Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009; 17:241–251.
9. Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, Lee DH, Lee KH. Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016; 48:436–450.
10. Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, Yun YH. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage. 2008; 35:644–655.
11. Kim SH, Kang S, Kim YM, Kim BG, Seong SJ, Cha SD, Park CY, Yun YH. Prevalence and predictors of anxiety and depression among cervical cancer survivors in Korea. Int J Gynecol Cancer. 2010; 20:1017–1024.
12. Goo AJ, Song YM, Shin J, Ko H. Factors associated with depression assessed by the Patient Health Questionnaire-2 in long-term cancer survivors. Korean J Fam Med. 2016; 37:228–234.
13. Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv. 2015; 9:481–491.
14. Shim EJ, Shin YW, Oh DY, Hahm BJ. Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry. 2010; 32:169–175.
15. Sperber AD. Translation and validation of study instruments for cross-cultural research. Gastroenterology. 2004; 126:S124–S128.
16. Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004; 13:863–868.
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–370.
18. Oh SM, Min KJ, Park DB. A study on the standardization of the Hospital Anxiety and Depression Scale for Koreans: a comparison of normal, depressed and anxious groups. J Korean Neuropsychiatr Assoc. 1999; 38:289–296.
19. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989; 46:1121–1123.
20. Chung KI, Song CH. Clinical usefulness of fatigue severity scale for patients with fatigue, and anxiety or depression. Korean J Psychosom Med. 2001; 9:164–173.
21. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. 1999; 6:1–55.
22. Fleiss JL. Design and Analysis of Clinical Experiments. New York, NY: Wiley;1999.
23. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 4th ed. Boston, MA: Allyn and Bacon;2001.
24. Shim EJ, Mehnert A, Koyama A, Cho SJ, Inui H, Paik NS, Koch U. Health-related quality of life in breast cancer: a cross-cultural survey of German, Japanese, and South Korean patients. Breast Cancer Res Treat. 2006; 99:341–350.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr